Ayurvedic Treatment Package in Plaque Psoriasis

NCT ID: NCT04146558

Last Updated: 2025-06-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-12-04

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Psoriasis is a chronic, immune-mediated inflammatory skin disease that is associated with substantial impairment of physical and psychological quality of life. The conventional treatment protocols manages the condition but with remissions and relapses which create anxiety in patients. Many of the patients withdraw from active social life as the disease attains chronicity. Several studies are pointing towards a conjoint management strategy incorporating the traditional and alternate medical systems. In this regard, Ayurveda is commonly used by psoriatic patients in India. Considering this fact it is high time to conduct a study to scientifically evaluate the efficacy of Ayurvedic treatment protocol in managing psoriasis as well as its potential to improve the quality of life.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Psoriasis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Internal ayurvedic treatment

All possible internal preparations will be administered for a period of 12 months.

All administered preparations with its dosage and duration will be documented All preparations will be subjected to lab test for clearing heavy metal and pesticide content before the administration

Group Type EXPERIMENTAL

Individualized internal ayurvedic treatment

Intervention Type DRUG

All possible internal preparations will be administered for a period of 12 months.

All administered preparations with its dosage and duration will be documented All preparations will be subjected to lab test for clearing heavy metal and pesticide content before the administration

External ayurvedic treatment

Application of warm external oil (Ayyapala kera tailam) on affected parts twice daily

Group Type ACTIVE_COMPARATOR

External ayurvedic treatment

Intervention Type OTHER

Application of warm external oil (Ayyapala kera tailam) on affected parts twice daily

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Individualized internal ayurvedic treatment

All possible internal preparations will be administered for a period of 12 months.

All administered preparations with its dosage and duration will be documented All preparations will be subjected to lab test for clearing heavy metal and pesticide content before the administration

Intervention Type DRUG

External ayurvedic treatment

Application of warm external oil (Ayyapala kera tailam) on affected parts twice daily

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with psoriasis having age 18 years or more
* Patients with moderate-to-severe plaque psoriasis with a PASI score of 12 or higher
* Psoriasis diagnosed 6 months or more before study entry
* Those who are poorly controlled based on physicians assessment with topical treatments, phototherapy, systemic therapy, or a combination of these therapies.
* Participants who have given informed consent.

Exclusion Criteria

* Participants with other systemic illnesses
* Lactating and pregnant mothers.
* Alcohol dependence/Narcotic dependence /Steroid dependence
* In the judgment of the investigator, unable or unwilling to follow the protocol and instructions
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Poomulli Neelakandan Namboodiripad Memorial Ayurveda Medical College

UNKNOWN

Sponsor Role collaborator

Universität Duisburg-Essen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Holger Cramer

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

PNNM Ayurveda College

Shōranūr, Kerala, India

Site Status

Countries

Review the countries where the study has at least one active or historical site.

India

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GI012019

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Low-Dose Enoxaparin in Psoriasis
NCT06416566 NOT_YET_RECRUITING NA
Natural Gels for Treatment of Plaque Psoriasis
NCT02330237 COMPLETED PHASE2/PHASE3
A Herbal Compound for Psoriasis
NCT06301997 ACTIVE_NOT_RECRUITING PHASE2